Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response

Marcel, V; Fernandes, K; Terrier, O; Lane, D P; Bourdon, J-C
September 2014
Cell Death & Differentiation;Sep2014, Vol. 21 Issue 9, p1377
Academic Journal
In addition to the tumor suppressor p53 protein, also termed p53α, the TP53 gene produces p53β and p53γ through alternative splicing of exons 9β and 9γ located within TP53 intron 9. Here we report that both TG003, a specific inhibitor of Cdc2-like kinases (Clk) that regulates the alternative splicing pre-mRNA pathway, and knockdown of SFRS1 increase expression of endogenous p53β and p53γ at mRNA and protein levels. Development of a TP53 intron 9 minigene shows that TG003 treatment and knockdown of SFRS1 promote inclusion of TP53 exons 9β/9γ. In a series of 85 primary breast tumors, a significant association was observed between expression of SFRS1 and α variant, supporting our experimental data. Using siRNA specifically targeting exons 9β/9γ, we demonstrate that cell growth can be driven by modulating p53β and p53γ expression in an opposite manner, depending on the cellular context. In MCF7 cells, p53β and p53γ promote apoptosis, thus inhibiting cell growth. By transient transfection, we show that p53β enhanced p53α transcriptional activity on the p21 and Bax promoters, while p53γ increased p53α transcriptional activity on the Bax promoter only. Moreover, p53β and p53γ co-immunoprecipitate with p53α only in the presence of p53-responsive promoter. Interestingly, although p53β and p53γ promote apoptosis in MCF7 cells, p53β and p53γ maintain cell growth in response to TG003 in a p53α-dependent manner. The dual activities of p53β and p53γ isoforms observed in non-treated and TG003-treated cells may result from the impact of TG003 on both expression and activities of p53 isoforms. Overall, our data suggest that p53β and p53γ regulate cellular response to modulation of alternative splicing pre-mRNA pathway by a small drug inhibitor. The development of novel drugs targeting alternative splicing process could be used as a novel therapeutic approach in human cancers.


Related Articles

  • Integrated high-throughput analysis identifies Sp1 as a crucial determinant of p53-mediated apoptosis. Li, H; Zhang, Y; Ströse, A; Tedesco, D; Gurova, K; Selivanova, G // Cell Death & Differentiation;Sep2014, Vol. 21 Issue 9, p1493 

    The restoration of p53 tumor suppressor function is a promising therapeutic strategy to combat cancer. However, the biological outcomes of p53 activation, ranging from the promotion of growth arrest to the induction of cell death, are hard to predict, which limits the clinical application of...

  • The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms. Kovacevic, Zaklina; Sivagurunathan, Sutharshani; Mangs, Helena; Chikhani, Sherin; Zhang, Daohai; Richardson, Des R. // Carcinogenesis;May2011, Vol. 32 Issue 5, p732 

    The metastasis suppressor, N-myc downstream regulated gene-1 (NDRG1), has been shown to markedly reduce metastasis of numerous tumors. The current study was focused on further elucidating the molecular mechanisms behind the antitumor function of NDRG1. We have identified for the first time that...

  • Che-ating death: CHE1/AATF protects from p53-mediated apoptosis. Jackson, James G; Lozano, Guillermina // EMBO Journal;10/17/2012, Vol. 31 Issue 20, p3951 

    No abstract available.

  • p53 and Retinoblastoma protein (pRb): A complex network of interactions. Godefroy, N.; Lemaire, C.; Mignotte, B.; Vayssière, J.-L. // Apoptosis;Sep2006, Vol. 11 Issue 5, p659 

    The article focuses on the regulation of the apoptotic function of p53 protein by the Retinoblastoma protein (pRb). It has been observed in rat cell culture that the caspase-9 cleaves pRb and the cleavage generates a truncated form of pRb, named p76Rb. This cleavage as an antagonist of p53...

  • The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML. Kojima, K.; Shimanuki, M.; Shikami, M.; Samudio, I. J.; Ruvolo, V.; Corn, P.; Hanaoka, N.; Konopleva, M.; Andreeff, M.; Nakakuma, H. // Leukemia (08876924);Sep2008, Vol. 22 Issue 9, p1728 

    Activation of the phosphatidylinositol-3 kinase/Akt/mammalian target of the rapamycin (PI3K/Akt/mTOR) pathway and inactivation of wild-type p53 by murine double minute 2 homologue (Mdm2) overexpression are frequent molecular events in acute myeloid leukemia (AML). We investigated the interaction...

  • The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele. Shetzer, Y; Kagan, S; Koifman, G; Sarig, R; Kogan-Sakin, I; Charni, M; Kaufman, T; Zapatka, M; Molchadsky, A; Rivlin, N; Dinowitz, N; Levin, S; Landan, G; Goldstein, I; Goldfinger, N; Pe'er, D; Radlwimmer, B; Lichter, P; Rotter, V; Aloni-Grinstein, R // Cell Death & Differentiation;Sep2014, Vol. 21 Issue 9, p1419 

    p53 loss of heterozygosity (p53LOH) is frequently observed in Li-Fraumeni syndrome (LFS) patients who carry a mutant (Mut) p53 germ-line mutation. Here, we focused on elucidating the link between p53LOH and tumor development in stem cells (SCs). Although adult mesenchymal stem cells (MSCs)...

  • Biological and molecular characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis. Maxwell, S. A.; Davis, G. E. // Apoptosis;Jun2000, Vol. 5 Issue 3, p277 

    Upregulation of the p53 tumor suppressor protein by infection with a recombinant p53 adenovirus resulted in extensive apoptosis in ECV-304 cells and the eventual death of almost all the cells. To establish a system to elucidate the molecular mechanisms involved in p53-mediated apoptosis of these...

  • Versatile functions of p53 protein in multicellular organisms. Chumakov, P. M. // Biochemistry (00062979);Dec2007, Vol. 72 Issue 13, p1399 

    The p53 tumor suppressor plays a pivotal role in multicellular organism by enforcing benefits of the organism over those of an individual cell. The task of p53 is to control the integrity and correctness of all processes in each individual cell and in the organism as a whole. Information about...

  • The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex. Boominathan, Lakshmanane // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    The tumor suppressors p53, p73, and p63 are known to function as transcription factors. They promote either growth arrest or apoptosis, depending upon the DNA damage. A number of microRNAs (miRNAs) have been shown to function as transcriptional targets of p53 and they appear to aid p53 in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics